A lack of clinically useful diagnostics has prevented personalized medicine from living up to some of the eager projections made in the wake of the completion of the human genome project, a Tufts report has concluded.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.